{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:21:40Z","timestamp":1776705700045,"version":"3.51.2"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1124\/dmd.118.084640","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T21:05:18Z","timestamp":1544475918000},"page":"238-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hydrolytic Metabolism of Cyanopyrrolidine DPP-4 Inhibitors Mediated by Dipeptidyl Peptidases"],"prefix":"10.1016","volume":"47","author":[{"given":"Fandi","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.118.084640_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/dmd.114.062331","article-title":"Dipeptidyl peptidase-4 greatly contributes to the hydrolysis of vildagliptin in human liver","volume":"43","author":"Asakura","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084640_bib2","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1021\/jm050261p","article-title":"Discovery and preclinical profile of saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes","volume":"48","author":"Augeri","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.118.084640_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bmcl.2006.10.012","article-title":"Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor","volume":"17","author":"Danilova","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.118.084640_bib4","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1046\/j.1432-1327.2000.01634.x","article-title":"Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26\/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides","volume":"267","author":"Durinx","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1124\/dmd.118.084640_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"10.1124\/dmd.118.084640_bib6","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1021\/jm100762r","article-title":"Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore","volume":"53","author":"Fleming","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.118.084640_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/00498254.2012.731618","article-title":"Pharmacokinetics and metabolism of [14C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans","volume":"43","author":"Furuta","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.118.084640_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1262-3636(07)70190-8","article-title":"Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes","volume":"31","author":"Gautier","year":"2005","journal-title":"Diabetes Metab"},{"key":"10.1124\/dmd.118.084640_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.regpep.2013.07.003","article-title":"DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues","volume":"186","author":"Harstad","year":"2013","journal-title":"Regul Pept"},{"key":"10.1124\/dmd.118.084640_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/dmd.108.023010","article-title":"Absorption, metabolism, and excretion of [14C]vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans","volume":"37","author":"He","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084640_bib11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1124\/dmd.108.023002","article-title":"Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs","volume":"37","author":"He","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084640_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.abb.2005.11.010","article-title":"Mechanism of Gly-Pro-pNA cleavage catalyzed by dipeptidyl peptidase-IV and its inhibition by saxagliptin (BMS-477118)","volume":"445","author":"Kim","year":"2006","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.118.084640_bib13","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.2174\/092986709788803114","article-title":"Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme","volume":"16","author":"Matteucci","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1124\/dmd.118.084640_bib14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1107\/S0907444903010059","article-title":"High-resolution structure of human apo dipeptidyl peptidase IV\/CD26 and its complex with 1-[([2-[(5-iodopyridin-2-yl)amino]-ethyl]amino)-acetyl]-2-cyano-(S)-pyrrolidine","volume":"59","author":"Oefner","year":"2003","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/dmd.118.084640_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1124\/dmd.112.045450","article-title":"Characterization of the in vitro and in vivo metabolism and disposition and cytochrome P450 inhibition\/induction profile of saxagliptin in human","volume":"40","author":"Su","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084640_bib16","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0969-2126(03)00160-6","article-title":"Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV","volume":"11","author":"Thoma","year":"2003","journal-title":"Structure"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.118.084640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:19:11Z","timestamp":1739956751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624077675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0090955624077675"],"URL":"https:\/\/doi.org\/10.1124\/dmd.118.084640","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrolytic Metabolism of Cyanopyrrolidine DPP-4 Inhibitors Mediated by Dipeptidyl Peptidases","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.118.084640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}